🤝 Build a Multi-Six Figure Biz Through Social Media

Together with

Together with Section

Join the AI ROI Conference on September 25 - Free Virtual Conference on Generating Real ROI with AI

On September 25, get the expert formula for turning AI spend into ROI at your organization at Section's virtual AI ROI conference.

No gatekeeping, no pitching, no BS. Hear from top AI leaders like Scott Galloway, Mo Gawdat, and May Habib and leave with a clear path to AI ROI for your company.

Upcoming Events

Business News

Trump Calls for Intel CEO’s Resignation

Intel shares dipped after former President Trump publicly demanded CEO Lip-Bu Tan step down, calling him “highly conflicted” due to alleged connections to Chinese military-linked companies. The criticism echoes concerns raised by Senator Tom Cotton, who questioned Tan’s past investments and their implications for national security especially with Intel receiving U.S. taxpayer funding. Tan, who took the helm in March, is already under pressure as he slashes spending and scales back chip production projects in a bid to reverse Intel’s financial slide.

Eli Lilly Surges Past Q2 Expectations

Eli Lilly raised its full-year 2025 outlook after posting blockbuster Q2 results, driven by massive demand for its diabetes and weight loss drugs, Mounjaro and Zepbound. The company now expects revenue between $60–$62 billion and adjusted earnings up to $23 per share both upgrades from previous guidance. Q2 revenue soared 38% to $15.56 billion, with Mounjaro generating $5.2 billion and Zepbound hitting $3.38 billion in sales, far exceeding analyst expectations. Despite the strong financials, shares dropped up to 12% premarket after clinical trial data for its new obesity pill, orforglipron, underwhelmed Wall Street. CEO David Ricks remained optimistic, touting the company’s momentum and pipeline potential. The report also comes amid policy pressures from President Trump, who has revived efforts to slash U.S. drug prices and imposed new pharma tariffs.

Together with Pacaso

Together with

Big investors are buying this “unlisted” stock

When the founder who sold his last company to Zillow for $120M starts a new venture, people notice. That’s why the same VCs behind Uber and eBay also backed Pacaso. They made $110M+ in gross profit to date. They even reserved the Nasdaq ticker PCSO. Now, you can join, too.

Invest for $2.90/Share

_{Paid advertisement for Pacaso’s Regulation A offering. Read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals.}

Tip of the Day

The fastest way to grow is to simplify

More offers, more platforms, more content? That’s not growth that’s noise. Refine your one path to revenue, then double down. Simplicity scales, complexity stalls.